Double-blind Study of Nimodipine in Non-Severe Stroke

Completed

Phase 2 Results

Eligibility Criteria

Inclusion Criteria

Patients within 48 h of infarct and after CT, Mathew scale sum score between 50 and 75, aged 39-85 years, informed consent of patient or relative.

Exclusion Criteria

Rapid improvement within the first 24 hours, progressing stroke, loss of consciousness, brainstem infarction, pregnancy, cerebral neoplasm, etiology of brain infarction not involving atherothromboembolic factors, other severe diseases making it impractical to be included in the study.